Institution statistics

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - France 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:400-500
Networking Rank (Reputation):300-400
Partner Constancy:300-400
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):900-1000
2013
Criterium:Position:
Overall Score:500-600
Total Project Funding:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:64
Partner Constancy:50
Project Leadership Index:69
Diversity Index:41
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:61
Networking Rank (Reputation):200-300
Networking Rank (Reputation):200-300
Partner Constancy:43
Project Leadership Index:66
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding:200-300
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):400-500
Partner Constancy:300-400
Project Leadership Index:300-400
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):300-400
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:400-500
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:800-900
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 132
As coordinator: 9
As participant: 123
Sole participant: 0
Coordinator / Participant Ratio: 0.07*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 6.189.570 76.538.976 4.391.652 1 9
2016 0 11.598.619 1.864.316 3
2015 0 40.823.453 2.883.210 7
2014 4.500.962 5.206.530 1.432.925 1 3
2013 0 88.682.255 4.767.210 10
2012 5.900.000 62.332.099 5.830.700 1 10
2011 0 78.648.314 4.519.602 11
2010 5.983.478 49.989.501 3.122.563 1 6
2009 2.989.154 24.922.118 1.941.656 1 6
2008 0 26.208.018 2.081.006 8
2007 0 21.207.358 763.160 2
2006 0 57.771.199 3.541.212 7
2005 0 2.722.199 117.110 3
2004 0 13.004.284 634.946 4
2003 1.399.714 7.493.889 1.013.486 1 8
2002 4.225.544 14.120.850 1.783.616 3 10
2001 0 11.200.747 1.710.202 7
2000 0 13.704.602 1.535.403 9
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE38
UNIVERSITY COLLEGE LONDON34
KAROLINSKA INSTITUTE21
STICHTING KATHOLIEKE UNIVERSITEIT17
KATHOLIEKE UNIVERSITEIT LEUVEN14
KING'S COLLEGE LONDON12
CHARITE UNIVERSITAETSMEDIZIN BERLIN11
UNIVERSITAET ULM11
UNIVERSITY OF NEWCASTLE UPON TYNE11
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM10
UNIVERSITA DEGLI STUDI DI PADOVA10
INSERM TRANSFERT9
SERVICIO MADRILENO DE SALUD9
UNIVERSITAIR MEDISCH CENTRUM UTRECHT9
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER8
COMMISSARIAT A L'ENERGIE ATOMIQUE8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE8
UNIVERSITA DEGLI STUDI DI TORINO8
UNIVERSITY OF DUNDEE8
ASSOCIATION POUR LA RECHERCHE SUR LES TRANSPLANTATIONS MEDULLAIRES7
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE7
HEINRICHHEINEUNIVERSITAET DUESSELDORF7
ISTITUTO SUPERIORE DI SANITA7
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON7
REGION HOVEDSTADEN7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
THE UNIVERSITY OF LIVERPOOL7
UNIVERSITY OF BOLOGNA7
UNIVERSITY OF COPENHAGEN7
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM6
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM6
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES6
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O6
HELSINKI UNIVERSITY CENTRAL HOSPITAL6
INSTITUT CATALA DE LA SALUT6
INSTITUT PASTEUR6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN6
LUNDS UNIVERSITET6
MEDIZINISCHE HOCHSCHULE HANNOVER6
MEDIZINISCHE UNIVERSITAET WIEN6
STATENS SERUM INSTITUT6
THE UNIVERSITY OF SHEFFIELD6
UNIVERSITA CATTOLICA DEL SACRO CUORE6
UNIVERSITY OF BIRMINGHAM6
UNIVERSITY OF GLASGOW6
UNIVERSITY OF MANCHESTER6
UPPSALA UNIVERSITET6
ACADEMISCH ZIEKENHUIS GRONINGEN5
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER5
EBERHARD KARLS UNIVERSITAET TUEBINGEN5
GENETHON5
HLA ET MEDECINE5
HOSPICES CIVILS DE LYON5
LEIDEN UNIVERSITY5
LEIDEN UNIVERSITY MEDICAL CENTER5
MEDICAL RESEARCH COUNCIL5
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS5
THE UNIVERSITY OF MILANO5
THE UNIVERSITY OF NOTTINGHAM5
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA5
UNIVERSITAET BERN5
UNIVERSITAET LEIPZIG5
UNIVERSITAET ZUERICH5
UNIVERSITAETSKLINIKUM FREIBURG5
UNIVERSITAETSKLINIKUM HEIDELBERG5
UNIVERSITE DE GENEVE5
UNIVERSITE DE LIEGE5
UNIVERSITE DE PARIS VII DENIS DIDEROT5
UNIVERSITY OF HELSINKI5
UNIVERSITY OF TORINO5
UNIVERSITY OF WALES CARDIFF5
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
CENTRO S GIOVANNI DI DIO FATEBENEFRATELLI ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO4
CONSIGLIO NAZIONALE DELLE RICERCHE4
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA4
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA4
GENOME RESEARCH4
HOSPITAL CLINIC BARCELONA4
INSTITUT GUSTAVE ROUSSY4
INSTITUT PAOLI CALMETTES CENTRE REGIONAL DE LUTTRE CONTRE LE CANCER4
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI4
ISTITUTO GIANNINA GASLINI4
NATIONAL INSTITUTE OF PUBLIC HEALTH4
NATIONAL UNIVERSITY OF IRELAND GALWAY4
OSPEDALE PEDIATRICO BAMBINO GESU4
SERVEIS SANITARIS DE REFERENCIA CENTRE DE TRANFUSIO I BANC DE TEIXITS4
UNIVERSIDAD COMPLUTENSE DE MADRID4
UNIVERSITA DEGLI STUDI DI GENOVA4
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA4
UNIVERSITA DEGLI STUDI DI PERUGIA4
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS4
UNIVERSITE LIBRE DE BRUXELLES4
UNIVERSITEIT ANTWERPEN4
UNIVERSITY MEDICAL CENTRE UTRECHT4
Constancy:

Total number of partners:2073

Partner loyalty:
Frequent Partner: (> 2 projects): 862
Rare Partner: 1211

Frequent / Rare Partner Ratio: 0.71

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES91
RTD HORIZONTAL TOPICS43
SOCIAL AND ECONOMIC CONCERNS31
PROTECTING MAN AND HIS ENVIRON12
INDUSTRY AND TECHNOLOGY8
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88147
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANparticipant3.831.95810
2017-09-01An INtegrated next generation PREParedness programme for improving effective inter-organisational response capacity in complex environments of disasters and causes of crises IN-PREPparticipant7.999.55620
2017-06-01PAN EBOLA VACCINE INNOVATIVE APPROACH PEVIAcoordinator6.189.57013
2017-01-10Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY HARMONYparticipant20.200.00044
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80016
2017-01-01Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) ALIVERparticipant6.478.73811
2017-01-013-O-sulfated heparan sulfate translocation in altered membrane biology: A newstrategy for early population screening and halting Alzheimer’s neurodegeneration ArrestADparticipant3.991.0968
2017-01-01REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy RESPINEparticipant5.555.83614
2017-01-01Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection HIVACARparticipant6.685.11114
2016-10-01Expanding and extending gene therapy of monogenic diseases of the haematopoietic system GENE FOR CUREparticipant2.445.2682
2016-02-01Decision Support and Information Management System for Breast Cancer DESIREEparticipant3.340.72012
2016-01-01Imaging the Force of Cancer FORCEparticipant5.812.63116
2015-11-01EVA - patient ventilation beyond limits EVAparticipant1.890.0004
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25930
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014
2015-05-01I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly I-MOVE-plusparticipant7.482.72925
2015-05-01A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly EU-CaREparticipant5.593.04910
2015-05-01Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension ENSAT-HTparticipant7.607.33713
2015-01-01Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis ADIPOA2participant5.999.00018
2014-11-01Prevention and Management of High Threat Pathogen Incidents in Transport Hubs PANDHUBparticipant3.142.0046
2014-04-01Mimimally invasive retrograde targeting of aCAR lentiviral vector to non-human primate motor neurons RTLVNHPparticipant149.5262
2014-01-01Tissue engineering of the right heart outflow tract by a biofunctionalized bioresorbable polymeric valved tube TEH-TUBEcoordinator4.500.9627
2014-01-01Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics Lab2Goparticipant1.915.00010
2013-12-01A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients MERCURICparticipant5.999.99513
2013-10-01Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified. CFMATTERSparticipant5.999.74812
2013-10-01A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer GANNET53participant5.994.07218
2013-10-01Collaborative European NeuroTrauma Effectiveness Research in TBI CENTER-TBIparticipant29.998.90338
2013-09-01Semantics-driven Design through Geo and Building Information Modelling for Energy-efficient Buildings Integrated in Mixed-use Healthcare Districts STREAMERparticipant8.000.00020
2013-09-01Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock CULPRIT-SHOCKparticipant5.999.14517
2013-07-01GAbapentin in Paediatric Pain GAPPparticipant5.476.87515
2013-03-01Biomarkers of renal graft injuries in kidney allograft recipients BIOMARGINparticipant6.000.00013
2013-02-01Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility NANOATHEROparticipant9.833.34816
2013-01-01Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action EUROFANCOLENparticipant5.380.17011
2012-12-01Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) NET4CGDparticipant5.999.60711
2012-12-01A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches EUROSTAMparticipant2.623.50011
2012-11-01"Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration" OPTIMISTICparticipant3.000.0009
2012-11-01Clinical Development of Nitisinone for Alkaptonuria DEVELOPAKUREparticipant5.999.99913
2012-11-01Metagenomics in Cardiometabolic Diseases METACARDISparticipant11.999.99215
2012-10-01Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) DSD-LIFEparticipant2.999.95616
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2coordinator5.900.0006
2012-07-01Rapid Identification of Respiratory Tract Infections RID-RTIparticipant5.997.7376
2012-03-01European Consortium for the Early Treatment of Diabetic Retinopathy EUROCONDORparticipant5.998.76218
2012-01-01IMmune MOdulating strategies for treatment of MErkel cell Carcinoma IMMOMECparticipant5.717.97911
2011-11-01The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction BAMIparticipant5.993.08322
2011-10-01Evolution and Transfer of Antibiotic Resistance EVOTARparticipant11.997.39218
2011-10-01Resistance in Gram-Negative Organisms: Studying Intervention Strategies R-GNOSISparticipant11.999.99924
2011-10-01Patient-centric model for remote management, treatment and rehabilitation of autistic children MICHELANGELOparticipant2.871.9979
2011-03-01Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector GENEGRAFTparticipant4.961.65410

overview shows latest 50 from 132 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here:

Alias institution names:
  • ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
  • ASSISTANCE PUBLIQUEHOPITAUX DE PARIS HOPITAL NECKERENFANTS MALADES
  • ASSITANCE PUBLIQUE HOPITAUX DE PARIS CIC COCHIN

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: